Telescope Innovations (CSE:TELI) Installs Second Self-Driving Laboratory at Pfizer

Vancouver, British Columbia — February 23, 2026 — Leads & Copy — Telescope Innovations Corp. has announced the installation of its second Self-Driving Laboratory (SDL) at Pfizer, marking a key milestone in the multi-year agreement between the companies. The installation was completed in January 2026.

The SDL is designed to significantly reduce development timelines and generate cost savings. It is a leading-edge approach to chemistry research guided by artificial intelligence, informed by advanced process analytical technology, and executed by robotic automation.

Henry Dubina, CEO of Telescope Innovations, said the installation of the second SDL at one of the world’s largest pharmaceutical companies is a testament to the strength of their ongoing partnership with Pfizer. He added that beyond the potentially significant cost savings during drug development, the SDL aims to compress the development cycles which could enable the acceleration of new innovations into the market.

Dr. Jason Hein, Founder and CTO, added that with this second SDL deployment, they are pleased to continue demonstrating Physical AI at work, moving beyond digital models into the real world of chemistry, where the platform generates novel insights that could not be obtained through simulation alone. He noted that the core closed-loop architecture is directly transferable to any domain that requires rapid optimization of chemical or materials processes, from pharmaceutical innovation to advanced manufacturing and beyond.

The SDL is a fixed-position Physical AI platform that integrates collaborative robotics, real-time inline analytics (Process Analytical Technology, or PAT), and machine-learning-guided experimental design within a continuous, autonomous closed-loop workflow. The system sets up chemical reactions, measures kinetics in real time, and determines the next optimal experiment, all without researcher intervention, enabling 24/7 operation across multiple reaction vessels simultaneously. By dramatically increasing experimental throughput, the SDL accelerates the development of chemical synthesis methods by up to 100 times compared to traditional manual approaches.

Telescope Innovations Corp. is a developer of intelligent automation and advanced chemical manufacturing technologies. The Company builds and deploys enabling technologies including flexible robotic platforms and artificial intelligence software that improves experimental throughput, efficiency, and data quality. The Company’s Self-Driving Labs are fully autonomous, physical AI platforms that plan, execute, and analyze experiments far more efficiently than traditional manual approaches. Bio-pharmaceutical, high value specialty chemical, and advanced materials companies utilize Telescope’s products and services to accelerate the development and optimization of chemical processes, thereby cutting down time and costs from lab to market.

Source: Telescope Innovations Corp.

×

Welcome!

Biotech Reporter is the source most up-to-date real-time, direct-from-source News Tips and Story Leads.

By Subscribing you will receive Daily Biotech Update each day at 9:30 am ET (Market Open) in your inbox and you can unsubscribe any time.